P614 Proactive Infliximab is Superior to Either Conventional Infliximab and Vedolizumab in Inflammatory Bowel Disease
Journal of Crohn s and Colitis（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined